EP1922412A4 - Humanized antibody conjugates and related methods, assays, reagents, and kits - Google Patents

Humanized antibody conjugates and related methods, assays, reagents, and kits

Info

Publication number
EP1922412A4
EP1922412A4 EP06787249A EP06787249A EP1922412A4 EP 1922412 A4 EP1922412 A4 EP 1922412A4 EP 06787249 A EP06787249 A EP 06787249A EP 06787249 A EP06787249 A EP 06787249A EP 1922412 A4 EP1922412 A4 EP 1922412A4
Authority
EP
European Patent Office
Prior art keywords
kits
assays
reagents
humanized antibody
related methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06787249A
Other languages
German (de)
French (fr)
Other versions
EP1922412A2 (en
Inventor
Linda-Marie Anderson-Mauser
Mary Margaret Foltz
Robert John Dwyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of EP1922412A2 publication Critical patent/EP1922412A2/en
Publication of EP1922412A4 publication Critical patent/EP1922412A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP06787249A 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits Withdrawn EP1922412A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69961805P 2005-07-15 2005-07-15
US70836105P 2005-08-31 2005-08-31
PCT/US2006/027312 WO2007011698A2 (en) 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits

Publications (2)

Publication Number Publication Date
EP1922412A2 EP1922412A2 (en) 2008-05-21
EP1922412A4 true EP1922412A4 (en) 2009-07-15

Family

ID=37669378

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06787249A Withdrawn EP1922412A4 (en) 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits

Country Status (2)

Country Link
EP (1) EP1922412A4 (en)
WO (1) WO2007011698A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
EA200970834A1 (en) * 2007-03-06 2010-04-30 Рибовакс Байотекнолоджиз С.А. ANTIBODIES TO THE VIRUS VIRUS
CN103383393B (en) * 2013-06-28 2015-11-25 英科隆生物技术（杭州）有限公司 A kind of quality-control product of alternative patient's positive blood
CN108445224A (en) * 2018-02-26 2018-08-24 王贤俊 A kind of cardic fatty acid binding protein antibody fragment compounded latex particle and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681566A (en) * 1988-10-24 1997-10-28 3I Research Exploitation Limited Antibody conjugates with two or more covalently linked FC regions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3800048A1 (en) * 1987-05-14 1988-11-24 Boehringer Mannheim Gmbh METHOD FOR DETERMINING AN ANTIBODY IN HUMAN BODY LIQUIDS
US6051225A (en) * 1988-10-19 2000-04-18 The Dow Chemical Company Family of high affinity, modified antibodies for cancer treatment
DE3900534A1 (en) * 1989-01-10 1990-07-12 Boehringer Mannheim Gmbh DIAGNOSTIC PROOF USING CHIMAIR ANTIBODIES
US6015662A (en) * 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US5922845A (en) * 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US6630292B2 (en) * 2000-04-25 2003-10-07 Fuji Photo Film B.V. Method for producing a silver halide photographic emulsion
US6849259B2 (en) * 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681566A (en) * 1988-10-24 1997-10-28 3I Research Exploitation Limited Antibody conjugates with two or more covalently linked FC regions

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CAROSELLA E D ET AL: "Anti-human interleukin 2 receptor monoclonal antibody isotypic switching: Chimeric rat-human antibodies", HUMAN IMMUNOLOGY, NEW YORK, NY, US, vol. 29, no. 4, 1 December 1990 (1990-12-01), pages 233 - 246, XP023715811, ISSN: 0198-8859, [retrieved on 19901201] *
MORRISON S L: "IN VITRO ANTIBODIES: STRATEGIES FOR PRODUCTION AND APPLICATION", ANNUAL REVIEW OF IMMUNOLOGY, ANNUAL REVIEWS INC, US, vol. 10, 1 January 1992 (1992-01-01), pages 239 - 265, XP000983246, ISSN: 0732-0582 *
NEUBERGER M S ET AL: "A HAPTEN-SPECIFIC CHIMAERIC IGE ANTIBODY WITH HUMAN PHYSIOLOGICAL EFFECTOR FUNCTION", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 314, 21 March 1985 (1985-03-21), pages 268 - 270, XP001084105, ISSN: 0028-0836 *
TUNG E ET AL: "CHIMERIC ANTIBODY CONJUGATES FORMATION WITH HETEROBIFUNCTIONAL CROSS-LINKING REAGENTS", CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (TAIPEI), vol. 23, no. 2, 1990, & 13TH ANNUAL SCIENTIFIC MEETING OF THE CHINESE SOCIETY OF IMMUNOLOGY AND THE INTERNATIONAL SYMPOSIUM, XP009117782, ISSN: 0253-2662 *

Also Published As

Publication number Publication date
WO2007011698A2 (en) 2007-01-25
EP1922412A2 (en) 2008-05-21
WO2007011698A3 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
IL272883A (en) Monoclonal antibodies and uses thereof
IL264748B (en) Assay apparatuses, methods and reagents
SG10201404801YA (en) Monoclonal antibody
IL187710A0 (en) Anti-trkb monoclonal antibodies and uses thereof
IL227753A0 (en) Modified antibody or antibody fragment
IL177842A0 (en) Antibody calicheamicin conjugates
IL184152A0 (en) Monoclonal antibodies against nkg2a
IL206709A0 (en) Il-31 monoclonal antibodies
ZA200702793B (en) Humanized anti-5T4 antibodies and anti-5T4 antibody/calicheamicin conjugates
EP1940466A4 (en) Anti-addl monoclonal antibody and use thereof
IL191217A (en) Humanized monoclonal anti-il-17 antibodies
EP1964852A4 (en) Anti-ilt7 antibody
IL192604A0 (en) Anti-drug antibody assay
EP2322562A4 (en) Monoclonal antibody, and immunoassay using same
EP1877795A4 (en) Diagnostic serum antibody profiling
IL185781A0 (en) Antibodies against candida antigens
ZA200711153B (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
EP1718749A4 (en) Humanized antibody
ZA200706185B (en) Monoclonal antibodies against NKG2A
EP1922412A4 (en) Humanized antibody conjugates and related methods, assays, reagents, and kits
EP1956373A4 (en) Reagent for assaying antiphospholipid antibody and reagent for assaying anti-treponema pallidum antibody
WO2006116319A3 (en) Reagents that bind ccx-ckr2
EP1841782A4 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
ZA200707838B (en) Antibodies against Candida antigens
EP1712564A4 (en) Anti-nc1 monoclonal antibody

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080114

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20090612

17Q First examination report despatched

Effective date: 20091111

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20141022